Annual Total Liabilities
$17.29 M
-$299.00 M-94.53%
December 31, 2024
Summary
- As of March 13, 2025, AVBP annual total liabilities is $17.29 million, with the most recent change of -$299.00 million (-94.53%) on December 31, 2024.
- During the last 3 years, AVBP annual total liabilities has risen by +$15.47 million (+850.94%).
- AVBP annual total liabilities is now -94.53% below its all-time high of $316.29 million, reached on December 31, 2023.
Performance
AVBP Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$17.29 M
-$299.00 M-94.53%
December 31, 2024
Summary
- As of March 13, 2025, AVBP quarterly total liabilities is $17.29 million, with the most recent change of -$299.00 million (-94.53%) on December 31, 2024.
- Over the past year, AVBP quarterly total liabilities has increased by +$5.09 million (+41.75%).
- AVBP quarterly total liabilities is now -94.53% below its all-time high of $316.29 million, reached on December 31, 2023.
Performance
AVBP Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
AVBP Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -94.5% | +41.8% |
| 3 y3 years | +850.9% | +41.8% |
| 5 y5 years | +850.9% | +41.8% |
AVBP Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -94.5% | +850.9% | -94.5% | +70.9% |
| 5 y | 5-year | -94.5% | +850.9% | -94.5% | +70.9% |
| alltime | all time | -94.5% | +850.9% | -94.5% | +70.9% |
ArriVent BioPharma Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $17.29 M(-94.5%) | $17.29 M(-94.5%) |
| Sep 2024 | - | $316.29 M(+2493.4%) |
| Jun 2024 | - | $12.20 M(+20.6%) |
| Mar 2024 | - | $10.12 M(-96.8%) |
| Dec 2023 | $316.29 M | $316.29 M(+0.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2023 | - | $314.59 M(+2355.2%) |
| Jun 2023 | - | $12.81 M(-95.2%) |
| Dec 2022 | $267.94 M(>+9900.0%) | - |
| Dec 2022 | - | $267.94 M |
| Dec 2021 | $1.82 M | - |
FAQ
- What is ArriVent BioPharma annual total liabilities?
- What is the all time high annual total liabilities for ArriVent BioPharma?
- What is ArriVent BioPharma annual total liabilities year-on-year change?
- What is ArriVent BioPharma quarterly total liabilities?
- What is the all time high quarterly total liabilities for ArriVent BioPharma?
- What is ArriVent BioPharma quarterly total liabilities year-on-year change?
What is ArriVent BioPharma annual total liabilities?
The current annual total liabilities of AVBP is $17.29 M
What is the all time high annual total liabilities for ArriVent BioPharma?
ArriVent BioPharma all-time high annual total liabilities is $316.29 M
What is ArriVent BioPharma annual total liabilities year-on-year change?
Over the past year, AVBP annual total liabilities has changed by -$299.00 M (-94.53%)
What is ArriVent BioPharma quarterly total liabilities?
The current quarterly total liabilities of AVBP is $17.29 M
What is the all time high quarterly total liabilities for ArriVent BioPharma?
ArriVent BioPharma all-time high quarterly total liabilities is $316.29 M
What is ArriVent BioPharma quarterly total liabilities year-on-year change?
Over the past year, AVBP quarterly total liabilities has changed by +$5.09 M (+41.75%)